The pathogenesis of AD involves a complex interplay of genetic predisposition, immune dysregulation, and impaired epidermal barrier function, resulting in increased transepidermal water loss, altered skin microbiota, and chronic inflammatory responses predominantly driven by cytokines such as IL‐4, IL‐13, and IL‐31 [5]. This evidence concerns the gene IL13 and Alzheimer disease.